Migraine

From PAINWeek 2017: Reflex vasodilation is out, neurobiologic dysfunction is in as explanation for migraine etiology.

What Rx for adolescent migraineurs? Ideal care for menstrual migraine? Perfect patient for new CGRP inhibitors? Answers in this PCP Special Report.

Headache was a hot topic at the AAN Annual Meeting, and several studies have added to the literature. This slideshow summarizes the latest.

If you know that the FDA approved onabotulinumtoxinA to treat chronic migraine headache but aren't sure how it works, a neurologist explains.

A neurologist who treats headache has his eyes opened to the real possibility of marijuana as medicinal.

How to treat a pediatric problem that can easily turn into a lifelong issue?

If the cost savings of reduced healthcare access don’t justify the steep up front cost of BOTOX injections for chronic migraine, then someone is not doing his math correctly.

A combination of Vitamin D3 and simvastatin had an impressive effect on migraine frequency in a controlled study. How will this combo perform in real life? I'm cautiously optimistic.

If migraine is fundamentally an inflammatory problem and if inflammatory conditions increase cardiovascular risk, do migraineurs need statins?

An association was found between headache or non-migrainous headache and later dementia. Not so for migraine.

Promising new research is testing monoclonal antibodies delivered via infusion against CGRP, a powerful mediator of inflammation.

When it's time to try a triptan for migraine, remember there are 7 to choose from. If one doesn't work for your patient, another one in the class probably will.

Here's intriguing evidence that certain structural changes in the brain may be related to chronic migraines.

They work all week at stressful jobs without a headache--and spend the weekend in bed with a breakthrough migraine. What to do for them?

Do you know what drugs current guidelines recommend? Get an 8-slide update, here.

If one triptan doesn't work for your patient's migraines, try, try again. A neurologist offers tips on the pros and cons of the 6 available agents.

What it all boils down to: smoking is a risk factor for stroke--no matter your age or your migraine status.

By asking and answering these questions, I learned some new tricks that can help you help migraine sufferers.

What brings patients to your office-and not the specialty office down the street? Insights in this slideshow.

Triptan and ergotamine drugs are staples of acute migraine treatment. But questions about their cardiovascular safety linger in the absence of clear evidence. A short slide show looks at what we do know.

This benign, solitary, nodular tumor on the lower eyelid arises from the follicular infundibulum. What do you know about this condition and the 4 others in this quiz?

Better understanding of migraine causes and related issues could result in enhanced patient care and prevention, but clinicians face some serious challenges-here are 5.

Researchers are finding some useful answers about migraine treatment and prevention.

When is a headache more than just a headache? How best to treat a corneal ulcer? When can a patient with asthma safely undergo elective surgery? Here: tips to help you prepare for your recertification exam-and to help you in your daily practice.

In the news: respiratory disease underdiagnosed, Alzheimer biomarkers, Crohn disease microbiome, migraine device, sleep apnea and diabetes.

In the news: stroke prevention, heart disease and women, migraine and depression, cholinesterase inhibitors and dementia, multivitamins and cataract risk.

Chronic pain affects more Americans than diabetes mellitus, heart disease, and cancer combined. Here are some facts and figures about pain for you to consider.

Neurological disorders have been considered a significant threat to public health for some time. Take a look at these facts and figures.

The current study may help create new pathways for better understanding and developing more effective and more specific medications.

Most patients have a sophisticated idea of what causes their headaches, but the chances of this information being wrong are higher than desirable unless the patient formally experimented with triggers.